Search Results - "Vazart, C"

miR-31 as a prognostic and predictive marker of disease-free survival (DFS) in resected stage III colon cancer: A retrospective analysis of the PETACC-8 trial by Gaston Mathe, Y, Martin-Lannerée, S, Vazart, C, Fontaine, K, Mulot, C, Caumont, A, Montestruc, F, Le Malicot, K, Lepage, C, Taieb, J, Laurent-Puig, P

Get full text

Association of microRNA-21 (miR-21) with efficacy of cetuximab (cet) and bevacizumab (bev) in patients with metastatic colorectal cancer (mCRC) within the FIRE-3 study (AIO KRK-0306) by Miller-Phillips, L., Fischer von Weikersthal, L., Kaiser, F., Al-Batran, S.-E., Heintges, T., Neureiter, D., Kahl, C., Kullmann, F., Moehler, M., Scheithauer, W., Vazart, C., Fontaine, K., Held, S., Modest, D.P., Neumann, J., Jung, A., Kirchner, T., Heinemann, V., Stintzing, S.

Get full text

521PmiR-31 as a prognostic and predictive marker of disease-free survival (DFS) in resected stage III colon cancer: A retrospective analysis of the PETACC-8 trial by Gaston Mathe, Y, Martin-Lannerée, S, Vazart, C, Fontaine, K, Mulot, C, Caumont, A, Montestruc, F, Le Malicot, K, Lepage, C, Taieb, J, Laurent-Puig, P

Get full text

124PAssociation of microRNA-21 (miR-21) with efficacy of cetuximab (cet) and bevacizumab (bev) in patients with metastatic colorectal cancer (mCRC) within the FIRE-3 study (AIO KRK-0306) by Miller-Phillips, L, Fischer von Weikersthal, L, Kaiser, F, Al-Batran, S-E, Heintges, T, Neureiter, D, Kahl, C, Kullmann, F, Moehler, M, Scheithauer, W, Vazart, C, Fontaine, K, Held, S, Modest, D P, Neumann, J, Jung, A, Kirchner, T, Heinemann, V, Stintzing, S

Get full text

Mir31-3P Expression in Patients with Advanced Lepidic Adenocarcinoma (L-ADC) Treated with EGFR Tki in Ifct 0401 and 0504 Trials by Thiebaut, R., Wislez, M., Vazart, C., Decaulne, V., Mazieres, J., Friard, S., Merle, P., Morin, F., Liebaert, F., Cadranel, J.

Get full text

MiR-31-3p is a predictive biomarker of cetuximab response in FIRE3 clinical trial by Laurent-Puig, P., Grisoni, M.-L., Heinemann, V., Fontaine, K., Vazart, C., Decaulne, V., Rousseau, F., Courtieu, B., Lieabert, F., Jung, A., Neureiter, D., Thiébaut, R., Stintzing, S.

Get full text

543PMIR-31-3P IS A PREDICTIVE BIOMARKER OF CETUXIMAB EFFECTS IN A POST-HOC ANALYSIS IN THE NEW EPOC STUDY by Laurent-Puig, P., Bridgewater, J.A., Primrose, J., Pugh, S., Thomas, G.J., Moutasim, K., Rousseau, F., Fontaine, K., Vazart, C., Decaulne, V., Leclair, A., Genin, B., Imbeaud, S., Liebaert, F., Piasecka, B., Thiébaut, R.

“…Abstract Aim: miR-31-3p expression has been associated with progression-free survival (PFS) in KRAS wild type (WT) mCRC patients treated with anti-EGFR…”
Get full text

Mir-31-3P is a Predictive Biomarker of Cetuximab Effects in a Post-Hoc Analysis in the New Epoc Study by Laurent-Puig, P., Bridgewater, J.A., Primrose, J., Pugh, S., Thomas, G.J., Moutasim, K., Rousseau, F., Fontaine, K., Vazart, C., Decaulne, V., Leclair, A., Genin, B., Imbeaud, S., Liebaert, F., Piasecka, B., Thiébaut, R.

Get full text